HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meghna Jani Selected Research

Meghna Jani Research Topics

Disease

12Rheumatoid Arthritis
01/2021 - 09/2011
6Necrosis
01/2021 - 02/2015
3Infections
10/2022 - 01/2019
3Neoplasms (Cancer)
11/2021 - 01/2019
3Psoriatic Arthritis
01/2020 - 07/2015
2Musculoskeletal Diseases (Musculoskeletal Disease)
05/2022 - 11/2018
2Cancer Pain
11/2021 - 10/2020
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2019 - 02/2014
2Vasculitis (Vasculitides)
11/2018 - 01/2017
2Weight Gain
02/2018 - 01/2018
2Sleep Initiation and Maintenance Disorders (Insomnia)
02/2018 - 01/2018
1Stroke (Strokes)
10/2022
1Leukopenia
10/2022
1Myocardial Infarction
10/2022
1Pancytopenia
10/2022
1Colorectal Neoplasms (Colorectal Cancer)
10/2022
1Hypertension (High Blood Pressure)
01/2021
1Fibromyalgia (Fibrositis)
10/2020
1Substance-Related Disorders (Drug Abuse)
10/2020
1Alcoholism (Alcohol Abuse)
10/2020
1Synovitis
10/2020
1Drug-Related Side Effects and Adverse Reactions
02/2018
1Coinfection
12/2017
1Pneumonia (Pneumonitis)
12/2017
1Rheumatic Diseases (Rheumatism)
05/2015
1Interstitial Lung Diseases (Interstitial Lung Disease)
05/2014
1Joint Diseases (Joint Disease)
05/2014
1Crohn Disease (Crohn's Disease)
02/2014
1Cryptococcal Meningitis
09/2011
1Asthma (Bronchial Asthma)
10/2005

Drug/Important Bio-Agent (IBA)

13Pharmaceutical PreparationsIBA
05/2022 - 02/2014
9Biological ProductsIBA
05/2022 - 02/2014
8AntibodiesIBA
01/2021 - 02/2014
5Antirheumatic Agents (DMARD)IBA
01/2021 - 07/2015
4Etanercept (Enbrel)FDA Link
01/2021 - 05/2015
4GlucocorticoidsIBA
01/2021 - 06/2017
4Adalimumab (Humira)FDA Link
01/2021 - 05/2015
3Opioid Analgesics (Opioids)IBA
11/2021 - 01/2019
3Certolizumab PegolFDA Link
01/2021 - 01/2017
3Tumor Necrosis Factor InhibitorsIBA
01/2020 - 06/2017
2golimumabFDA Link
01/2021 - 06/2017
2Infliximab (Remicade)FDA Link
01/2021 - 06/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 05/2015
2tocilizumab (atlizumab)FDA Link
01/2019 - 06/2017
2SteroidsIBA
01/2019 - 10/2005
2Abatacept (Orencia)FDA Link
06/2017 - 03/2012
2Rituximab (Mabthera)FDA Link
06/2017 - 09/2011
2Methotrexate (Mexate)FDA LinkGeneric
06/2017 - 02/2014
1ImmunosorbentsIBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1A 17 (A-17)IBA
01/2021
1EnzymesIBA
01/2021
1C-Reactive ProteinIBA
10/2020
1MMEIBA
10/2020
1Pharmacological BiomarkersIBA
01/2020
1InterferonsIBA
06/2019
1Janus Kinase InhibitorsIBA
06/2017
1sarilumabIBA
06/2017
1Biosimilar PharmaceuticalsIBA
06/2017
1tofacitinibIBA
06/2017
1Sulfasalazine (Azulfidine)FDA LinkGeneric
06/2017
1sirukumabIBA
06/2017
1clazakizumabIBA
06/2017
1baricitinibIBA
06/2017
1Leflunomide (Arava)FDA LinkGeneric
06/2017
1Janus KinasesIBA
06/2017
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2015

Therapy/Procedure

4Therapeutics
11/2018 - 12/2017
3Biological Therapy
06/2019 - 05/2014
1Aftercare (After-Treatment)
10/2022
1Precision Medicine
07/2015